Roxatidine
- TRADE NAME: Roxit (Noristan)
- INDICATIONS: Gastric and duodenal ulcers
- CLASS: Histamine H2 receptor antagonist
- HALF-LIFE: 5–6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Please login to see the rest of this drug profile
SKIN.
CENTRAL NERVOUS SYSTEM.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
